Compare ALRM & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALRM | VCEL |
|---|---|---|
| Founded | 2000 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.4B |
| IPO Year | 2015 | 1996 |
| Metric | ALRM | VCEL |
|---|---|---|
| Price | $56.37 | $44.35 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 5 |
| Target Price | $56.67 | ★ $57.75 |
| AVG Volume (30 Days) | 384.4K | ★ 463.2K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 7.42 | ★ 60.00 |
| EPS | ★ 0.95 | N/A |
| Revenue | ★ $1,011,187,000.00 | $276,259,000.00 |
| Revenue This Year | $7.00 | $19.40 |
| Revenue Next Year | $4.53 | $18.24 |
| P/E Ratio | $59.23 | ★ N/A |
| Revenue Growth | 7.59 | ★ 16.45 |
| 52 Week Low | $41.49 | $28.95 |
| 52 Week High | $59.53 | $49.32 |
| Indicator | ALRM | VCEL |
|---|---|---|
| Relative Strength Index (RSI) | 63.36 | 49.50 |
| Support Level | $50.39 | $44.26 |
| Resistance Level | N/A | $49.04 |
| Average True Range (ATR) | 1.51 | 1.49 |
| MACD | 0.04 | -0.45 |
| Stochastic Oscillator | 79.15 | 28.36 |
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected device.
Vericel Corp is a fully integrated commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.